Randomized, Double-Blind, Placebo-Controlled Trial, with Cross-Over, of Posoleucel for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Allovir, Inc.
Start Date
May 23, 2022
End Date
March 31, 2025
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Allovir, Inc.
Start Date
May 23, 2022
End Date
March 31, 2025